Stealthy Sil­ver­back re­cruits Seat­tle Ge­net­ics’ Er­ic Dob­meier as CEO, fill­ing C-suite with on­col­o­gy tal­ent

A stealthy Sil­ver­back Ther­a­peu­tics has been build­ing up its C-suite with top tal­ent from a pair of high pro­file biotechs in the Seat­tle area.

Geek­Wire re­port­ed over the week­end that Sil­ver­back re­cruit­ed Seat­tle Ge­net­ics $SGEN COO Er­ic Dob­meier to take the helm at Sil­ver­back. Seat­tle Ge­net­ics re­port­ed Dob­meier’s planned de­par­ture in an SEC fil­ing on Fri­day.

Or­bimed’s Pe­ter Thomp­son came in with a $10 mil­lion ante to a $60 mil­lion launch round last year, paving the way to re­cruit­ing Seat­tle Ge­net­ics’ VP of man­u­fac­tur­ing Mike Sun. And the tech wire ser­vice added that Juno con­tributed Sam Black­man, a se­nior med­ical di­rec­tor at the I/O com­pa­ny, as head of clin­i­cal de­vel­op­ment while Va­lerie Ode­gard stepped over to be­come SVP of re­search.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER